Breast Cancer Trial Results
11. Anthracyclines Improve Survival for HER2-Positive, But Not HER2-Negative, Breast Cancer
(Posted: 01/30/2008) - Chemotherapy with an anthracycline drug such as doxorubicin or epirubicin extends survival for women with HER2-positive, but not HER2-negative, breast cancer, according to a meta-analysis published in the Jan. 2, 2008, Journal of the National Cancer Institute.
12. Extra Fruits and Vegetables Don't Cut Risk of Further Breast Cancer: Results of the WHEL Study
(Posted: 09/26/2007) - In the WHEL study, a diet high in fruits, vegetables, and fiber and somewhat lower in fat did not protect early-stage breast cancer survivors from further breast cancer, nor did it help them live longer, according to the July 18, 2007, Journal of the American Medical Association.
13. Hypnosis Before Breast-Cancer Surgery Reduces Pain, Discomfort, and Cost
(Posted: 09/12/2007) - Women undergoing surgery for breast cancer who received hypnosis before entering the operating room required less anesthesia and pain medication during surgery, and reported less pain, nausea, fatigue, and discomfort after surgery than women who did not receive hypnosis, according to the Sept. 5, 2007, Journal of the National Cancer Institute.
14. Breast Cancer Survivors Test Diet High in Fruits, Veggies
(Posted: 07/25/2007) - Breast cancer survivors who adopted a low-fat diet rich in vegetables, fruit, and fiber did not reduce their risk of recurrence, according to the July 18, 2007, Journal of the American Medical Association.
15. Boost Radiation Beneficial in Early-Stage Breast Cancer
(Posted: 07/11/2007) - In women with early-stage breast cancer who had been treated with breast-conserving lumpectomy and radiation, an additional "boost" dose of radiation to the original tumor site reduced the risk of cancer coming back in the same breast, though it did not help them live longer, according to the Aug. 1, 2007, Journal of Clinical Oncology.
< Previous 1 2 3 4 5 6 Next >
|
